Bond Screener
Mallinckrodt International Finance
LEI 549300MQQ92LN1A0B514
The issuer's bonds defaulted in 2023
Organization name
Mallinckrodt International Finance S.A.
Country name
Switzerland
Country of registration
Luxembourg
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
1,873 mln USD
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access
-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Mallinckrodt International Finance S.A., through its subsidiaries, develops medicines and other pharmaceutical products. Mallinckrodt International Finance S.A. was incorporated in 2012 and is based in Luxembourg. Mallinckrodt International Finance S.A. operates as a subsidiary of Mallinckrodt Public Limited Company.
|
General information
-
Organization nameMallinckrodt International Finance S.A.
-
Organization statusOperating organization
